Oculis Holding AG OCS
NASDAQ OCS
$8.78 +0.02 (+0.23%)
As of: Oct 2, 2026 · 10:13 AM EDT

Oculis Holding AG (OCS) Depreciation & Amortization (CF) (2022 - 2026)

Updated

Oculis Holding AG's Depreciation & Amortization (CF) was $225,213 in Q2 2026, up 65.0% from $136,492 a year earlier and up 14.5% from the prior quarter.

Analysis

Oculis Holding AG (OCS) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Oculis Holding AG's Depreciation & Amortization (CF) was $809,573 through Jun 30, 2026, up 46.3% year-over-year; for FY2025, it came in at $683,139, up 48.0% from FY2024.

  • Depreciation & Amortization (CF) has now increased for four consecutive years, with a five-year compound annual growth rate of 43.9% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $461,501 in FY2024 (+42.6%), $323,551 in FY2023 (+3.2%), $313,437 in FY2022 (+225.5%) and $96,303 in FY2021 (-13.2%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2022.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for eight straight quarters, with growth averaging 53.2% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2023 (growth of 369.5%); the worst was Q4 2023 (a decline of 59.8%).
  • Per Business Quant data, OCS's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $196,659 (Q1 2026), $197,685 (Q4 2025) and $190,017 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Oculis Holding AG 487.95 Mn 487.95 Mn - 225,212.56
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 225,212.56
Mar 31, 2026 196,658.72
Dec 31, 2025 197,684.83
Sep 30, 2025 190,016.65
Jun 30, 2025 136,491.60
Mar 31, 2025 136,806.82
Dec 31, 2024 139,265.67
Sep 30, 2024 140,813.28
Jun 30, 2024 98,415.62
Mar 31, 2024 83,634.81
Dec 31, 2023 83,424.23
Sep 30, 2023 82,647.14
Jun 30, 2023 116,778.43
Mar 31, 2023 37,840.69
Dec 31, 2022 207,604.38
Sep 30, 2022 17,602.76
API Access

Oculis Holding AG Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OCS&period=max&api_key=YOUR_API_KEY